Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.

about

Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.

Item

http://www.wikidata.org/entity/Q50098670

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@en

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@nl

type

Item

label

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@en

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@nl

prefLabel

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@en

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@nl

P1476

Acute autoimmune hemolytic ane ...... sfully treated with rituximab.

@en

P2093

Austin Turner

http://www.w3.org/2001/XMLSchema#string

David Head

http://www.w3.org/2001/XMLSchema#string

Elena Nedelcu

http://www.w3.org/2001/XMLSchema#string

Jennifer Green

http://www.w3.org/2001/XMLSchema#string

Kathleen M Bensing

http://www.w3.org/2001/XMLSchema#string

Megan Desai

http://www.w3.org/2001/XMLSchema#string

Pampee P Young

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.

Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.

Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?

Hemolytic anemia due to warm autoantibodies.

Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment.

Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination.

Further studies on the relationship of anti-Ena and anti-Wrb in warm autoimmune hemolytic anemia.

P304

176-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.14363

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29023757

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody